Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Loverix

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Medicinal Chemistry|April 8, 2003
Ribonucleases: from prototypes to therapeutic targets?Stefan Loverix, Jan Steyaert
The Journal of Physical Chemistry. B|February 14, 2006
Origin of the pKa perturbation of N-terminal cysteine in alpha- and 3(10)-helices: a computational DFT studyGoedele Roos, Stefan Loverix, Paul Geerlings
Nucleic Acids Research|March 25, 2005
Influence of the pi-pi interaction on the hydrogen bonding capacity of stacked DNA/RNA basesPierre Mignon, Stefan Loverix, Jan Steyaert, et al.
Journal of Molecular Biology|March 31, 2004
Leaving group activation by aromatic stacking: an alternative to general acid catalysisWim Versées, Stefan Loverix, An Vandemeulebroucke, et al.
The Journal of Biological Chemistry|July 18, 2002
A nucleophile activation dyad in ribonucleases. A combined X-ray crystallographic/ab initio quantum chemical studyPierre Mignon, Jan Steyaert, Remy Loris, et al.
The Journal of Biological Chemistry|February 8, 2005
Substrate-assisted leaving group activation in enzyme-catalyzed N-glycosidic bond cleavageStefan Loverix, Paul Geerlings, Michael McNaughton, et al.
Chembiochem : a European Journal of Chemical Biology|April 12, 2006
The activation of electrophile, nucleophile and leaving group during the reaction catalysed by pI258 arsenate reductaseGoedele Roos, Stefan Loverix, Elke Brosens, et al.
Chemical Communications (Cambridge, England)|October 5, 2018
Reviving old protecting group chemistry for site-selective peptide-protein conjugationSmita B Gunnoo, Abhishek Iyer, Willem Vannecke, et al.
Molecular Immunology|October 16, 2007
Non-immunized natural human heavy chain CDR3 repertoires allow the isolation of high affinity peptides mimicking a human influenza hemagglutinin epitopeSabrina Deroo, Aurélie Fischer, Nadia Beaupain, et al.
Nature Communications|October 31, 2014
Structural basis of IL-23 antagonism by an Alphabody protein scaffoldJohan Desmet, Kenneth Verstraete, Yehudi Bloch, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Medicinal Chemistry|April 8, 2003
Ribonucleases: from prototypes to therapeutic targets?Stefan Loverix, Jan Steyaert
The Journal of Physical Chemistry. B|February 14, 2006
Origin of the pKa perturbation of N-terminal cysteine in alpha- and 3(10)-helices: a computational DFT studyGoedele Roos, Stefan Loverix, Paul Geerlings
Nucleic Acids Research|March 25, 2005
Influence of the pi-pi interaction on the hydrogen bonding capacity of stacked DNA/RNA basesPierre Mignon, Stefan Loverix, Jan Steyaert, et al.
Journal of Molecular Biology|March 31, 2004
Leaving group activation by aromatic stacking: an alternative to general acid catalysisWim Versées, Stefan Loverix, An Vandemeulebroucke, et al.
The Journal of Biological Chemistry|July 18, 2002
A nucleophile activation dyad in ribonucleases. A combined X-ray crystallographic/ab initio quantum chemical studyPierre Mignon, Jan Steyaert, Remy Loris, et al.
The Journal of Biological Chemistry|February 8, 2005
Substrate-assisted leaving group activation in enzyme-catalyzed N-glycosidic bond cleavageStefan Loverix, Paul Geerlings, Michael McNaughton, et al.
Chembiochem : a European Journal of Chemical Biology|April 12, 2006
The activation of electrophile, nucleophile and leaving group during the reaction catalysed by pI258 arsenate reductaseGoedele Roos, Stefan Loverix, Elke Brosens, et al.
Chemical Communications (Cambridge, England)|October 5, 2018
Reviving old protecting group chemistry for site-selective peptide-protein conjugationSmita B Gunnoo, Abhishek Iyer, Willem Vannecke, et al.
Molecular Immunology|October 16, 2007
Non-immunized natural human heavy chain CDR3 repertoires allow the isolation of high affinity peptides mimicking a human influenza hemagglutinin epitopeSabrina Deroo, Aurélie Fischer, Nadia Beaupain, et al.
Nature Communications|October 31, 2014
Structural basis of IL-23 antagonism by an Alphabody protein scaffoldJohan Desmet, Kenneth Verstraete, Yehudi Bloch, et al.
Pageof 2